COURSE CO-DIRECTORS

Salvatore Albani, MD, PhD
Director, Translational Research Unit
Clinical Investigation Institute
Professor of Medicine and Pediatrics
University of California, San Diego
La Jolla, California

Gary S. Firestein, MD
Professor of Medicine
Chief, Division of Rheumatology, Allergy and Immunology
Director, UCSD Clinical Investigation Institute (CII)
University of California, San Diego
La Jolla, California

Ravindra L. Mehta, MD, MBBS, FACP
Director, Education Unit
Clinical Investigation Institute
Professor of Medicine
University of California, San Diego
La Jolla, California

Organizing Committee

Salvatore Albani, MD, PhD
Director, Translational Research Unit
Clinical Investigation Institute
Professor of Medicine and Pediatrics
University of California, San Diego
La Jolla, California

Michael Basson, PhD
Associate Editor
Nature Medicine

New York, New York

Gary S. Firestein, MD
Professor of Medicine
Chief, Division of Rheumatology, Allergy and Immunology
Director, UCSD Clinical Investigation Institute (CII)
University of California, San Diego
La Jolla, California

Dilip V. Jeste, MD
Estelle and Edgar Levi Chair in Aging
Director, Sam and Rose Stein Institute for Research on Aging
Distinguished Professor of Psychiatry and Neurosciences
La Jolla, California

Juan Carlos Lopez, PhD
Chief Editor
Nature Medicine
New York, New York

Ravindra L. Mehta, MBBS, MD, FACP
Director, Education Unit
Clinical Investigation Institute
Professor of Medicine
University of California, San Diego
La Jolla, California

Disclosure
The University of California, San Diego Continuing Medical Education (UCSD CME) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity, and promote improvements or quality in healthcare. Faculty participating in UCSD sponsored CME programs are expected to disclose to the activity participants any conflict(s) of interest that may have a direct bearing on the subject matter in their role as planners or presenters. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the course content. UCSD CME has the following mechanisms in place to resolve conflicts of interest 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. UCSD CME will resolve all conflicts of interest prior to an educational activity being delivered to learners. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.

 

SPEAKERS

Salvatore Albani, MD, PhD
Director, Translational Research Unit
Clinical Investigation Institute
Professor of Medicine and Pediatrics
University of California, San Diego
La Jolla, California

Steven Artandi, MD, PhD
Assistant Professor of Medicine
Cancer Biology Program
Stanford School of Medicine
Stanford, California

Michael Basson, PhD
Associate Editor
Nature Medicine
New York, New York

Joel Buxbaum, MD
Head, Division of Research Rheumatology
Keck Autoimmune Disease Center
Scripps Research Institute
La Jolla, California

Glenn R. Cunningham, MD
Professor of Medicine
Professor of Molecular and Cellular Biology
Baylor College of Medicine
Houston, Texas

Eric Daniels, MD
Cytori Therapeutics, Inc.
San Diego, California

Stefanie Dimmeler, PhD
University of Frankfurt
Frankfurt, Germany

Charles A. Dinarello, MD
Professor of Medicine
University of Colorado School of Medicine
Denver, Colorado

Laura L. Dugan, MD
Larry L. Hillbloom Chair in Geriatric Medicine
University of California, San Diego
La Jolla, California

Fred H. Gage, MD
Professor of Biology
The Salk Institute
La Jolla, California

David J. Glass, MD
Global Head, Muscle Diseases
Novartis Institutes for Biomedical Research
Cambridge, Massachusetts

Leonard Guarente, PhD
Novartis Professor of Biology
Massachusetts Institute of Technology
Cambridge, Massachusetts

Stanley L. Hazen, MD, PhD
Section Head, Preventive Cardiology and Rehabilitation
Director Center for Cardiovascular Diagnostics
Professor of Molecular Medicine
Cleveland Clinic
Cleveland, Ohio

Dilip V. Jeste, MD
University of California, San Diego
School of Medicine
La Jolla, California

David A. Kass, MD
Abraham and Virginia Weiss Professor of Cardiology
Professor of Biomedical Engineering
Division of Cardiology, Department of Medicine
Johns Hopkins Medical Institutions
Baltimore, Maryland

Nancy E. Lane, MD
Director and Endowed Professor
Aging Center, Medicine and Rheumatology
University of California at Davis Medical Center
Sacramento, California

Richard F. Loeser Jr., MD
Head, Section on Molecular Medicine
The Wake Forest University School of Medicine
Winston-Salem, NC

Anthony M. Manning, PhD
Vice-President, Inflammation and Autoimmune Diseases Research
Biogen Idec
Boston, Massachusetts

Mark P. Mattson, PhD
National Institute on Aging
Laboratory of Neurosciences
Baltimore, Maryland

Stephen J. Nicholls, MBBS, PhD, FRACP, FACC
Director, Intravascular Ultrasound Core Laboratory
Clinical Director, Center for Cardiovascular Diagnostics and Prevention
Associate Director, Cleveland Clinic Cardiovascular Coordinating Center
Cleveland Clinic, Department of Cardiovascular Medicine
Cleveland, Ohio

Lon S. Schneider, MD
Professor of Psychiatary, Neurology and Gerontology
Keck School of Medicine
University of Southern California
Los Angeles, California

Clay F. Semenkovich, MD
Herbert S. Gasser Professor
Chief, Division of Endocrinology, Metabolism and Lipid Research
Washington University
St. Louis, Missouri

Nancy A. Thornberry, MD
Merck Research Laboratories
Rahway, New Jersey